PRESS RELEASE | Basel, Switzerland, February 24, 2022

Versameb AG (“Versameb”), focused on discovering and developing innovative RNA-based drugs, today announces the formation of an Advisory Board comprised of industry leaders in urology. These include Professor Roger Dmochowski of Vanderbilt University, Professor Margot Damaser of the Cleveland Clinic Lerner College of Medicine, and Assistant Professor Frédéric Birkhäuser of St. Anna and Hirslanden Clinic Lucerne.

PRESS RELEASE | Basel, Switzerland, February 17, 2022

Versameb AG (“Versameb”), a pre-clinical stage company focused on discovering and developing innovative RNA-based therapeutics, today announces that its  Chief Scientific Officer, Friedrich Metzger will be presenting data on the Company’s mRNA engineering technology and lead therapeutic candidate, VMB-100, at the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) 2022 Winter Meeting, taking place on 22-26 February 2022 in San Diego, California.

PRESS RELEASE | Basel, Switzerland, January 5, 2022

Versameb AG (“Versameb”), a pre-clinical stage company focused on discovering and developing innovative RNA-based therapeutics, today announces that it will be attending Biotech Showcase: The Investor Conference for Innovators on the 10-12 January 2022. The Versameb team will be attending virtually.

PRESS RELEASE | Basel, Switzerland, November 4, 2021

Versameb AG (“Versameb”), a pre-clinical stage company focused on discovering and developing innovative RNA-based drugs, today announces that its Chief Scientific Officer, Friedrich Metzger, will be presenting data on its mRNA engineering technology and lead therapeutic candidate, VMB-100, at the 9th International mRNA Health Conference taking place on 9th and 10th November 2021 in Berlin.

PRESS RELEASE | Basel, Switzerland, October 4, 2021

Versameb AG (“Versameb”), a pre-clinical stage company focused on discovering and developing innovative RNA-based drugs, today announces its participation in the  21st Annual Biotech in Europe Forum organized by SACHS Associates taking place virtually 7th-8th October 2021.